SLC16A10 and Graves disease: Similarly, there was no obvious difference in relation to MCT10-aAb, and patients with Graves’ disease (n = 6), Hashimoto’s thyroiditis (n = 6) or other thyroid disease (n = 8) showed a similar prevalence of MCT10-aAb (Figure 5B).